Loading…

Pharmacokinetics of the phage endolysin‐based candidate drug SAL 200 in monkeys and its appropriate intravenous dosing period

Summary SAL 200 is a new phage endolysin‐based candidate drug for the treatment of staphylococcal infections. An intravenous administration study was conducted in monkeys to obtain pharmacokinetic information on SAL 200 and to assess the safety of a short SAL 200 dosing period (

Saved in:
Bibliographic Details
Published in:Clinical and experimental pharmacology & physiology 2016-10, Vol.43 (10), p.1013-1016
Main Authors: Jun, Soo Youn, Jung, Gi Mo, Yoon, Seong Jun, Youm, So Young, Han, Hyoung‐Yun, Lee, Jong‐Hwa, Kang, Sang Hyeon
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary SAL 200 is a new phage endolysin‐based candidate drug for the treatment of staphylococcal infections. An intravenous administration study was conducted in monkeys to obtain pharmacokinetic information on SAL 200 and to assess the safety of a short SAL 200 dosing period (
ISSN:0305-1870
1440-1681
DOI:10.1111/1440-1681.12613